gene 953 words KG: LGALS3
Contents

LGALS3 Gene

🧬 Gene Info
Gene SymbolLGALS3
Full NameLectin, Galactoside-Binding, Soluble, 3
Chromosome14
FunctionThe LGALS3 gene encodes Lectin, Galactoside-Binding, Soluble, 3, a protein expressed in various brain regions including the cerebral cortex, hippocampus, basal ganglia, and cerebellum.
Primary Expressionactivated microglia and plays complex roles in neuroinflammation - both promoting and resolving inflammatory responses
PathwaysAmyloid, Lipid Metabolism
UniProt IDP17931
Ensembl IDENSG00000131981
OMIM153619
GeneCardsLGALS3
Human Protein AtlasLGALS3
Associated DiseasesAD, ALI, Als, Alzheimer, Amyotrophic Lateral Sclerosis
Known Drugs/Compoundsrapamycin
InteractionsABCD3, ACTB, ALS, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE
SciDEX HypothesesGalectin-3 deletion attenuates NLRP3 inflammasome
Galectin-3 as Damage-Sensor Scaffold for Multimeri
Lectin-Mediated Autophagy Enhancers (+1 more)
KG Connections944 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

NCBI GeneUniProtGeneCardsWikipediaHGNCEnsembl

Related Hypotheses (32)

TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
RNA Granule Nucleation Site Modulation
Score: 0.66
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
FOXO3-Longevity Pathway Epigenetic Reprogramming
Score: 0.63
TREM2-Dependent Microglial Senescence Transition
Score: 0.62
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
HSP90-Tau Disaggregation Complex Enhancement
Score: 0.57
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.56
Cryptic Exon Silencing Restoration
Score: 0.53
← Prevpg 2/2

Related Analyses (8)

Synaptic pruning by microglia in early AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived

Related Experiments (22)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

See Also (9)

AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activates
ABCD3 Gene
gene · KG edge: interacts_with
ADAM10 — A Disintegrin And Metalloproteinase Domain 10
gene · KG edge: therapeutic_target
AMBRA1 Gene
gene · KG edge: interacts_with
Alzheimer Indonesia
institution · KG edge: activates

Knowledge Graph (12 edges)

CAT interacts_with LGALS3
OPTN interacts_with LGALS3
DNM1L interacts_with LGALS3
CANX interacts_with LGALS3
LGALS3 interacts_with CALCOCO2
LGALS3 interacts_with G3BP1
LGALS3 interacts_with PEX3
LGALS3 interacts_with SQSTM1
LGALS3 interacts_with BCL2
LGALS3 interacts_with STING1

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.